据美国食品药品管理局(FDA)消息,11月18日美国食品药品管理局(FDA)发布婴配食品标识当中声称所需科学依据的指南草案,并就此征求意见,截至日期为2017年2月21日。
婴儿奶粉标签与标识“结构/功能”声称是指产品的效果或者组分对正常结构或者身体功能的效果。例如奶粉标签上面的“助消化”。
部分原文报道如下:
The U.S. Food and Drug Administration has issued draft guidance for industry to help infant formula manufacturers making structure/function claims comply with the requirement that all claims in infant formula labels and labeling be truthful and not misleading.
“Structure/function” claims are statements made about the effects of a product or its constituent on the normal structure or function of the body. An example of a structure/function claim in infant formula labeling is a statement that the formula “supports digestion.”
In the draft guidance, “Substantiation for Structure/Function Claims Made in Infant Formula Labels and Labeling,” the FDA describes its recommendations for the type and quality of scientific evidence that is appropriate to substantiate (i.e., support) structure/function claims made about an infant formula by the product's manufacturers or distributors. The draft guidance provides recommendations with respect to all infant formulas, including formulas marketed for use by infants who have inborn errors of metabolism or low birth weight, or who otherwise have unusual medical or dietary problems.
原文链接:http://www.fda.gov/food/newsevents/constituentupdates/ucm514389.htm